Skip to content

edenceHealth

Active
Public limited companyfounded 20197 yrs activeVeldkant 33 A, 2550 Kontich, BelgiumKBO/BCE: BE 0719.961.021
Summary

edenceHealth has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€698,793) and a net result of -€152,200. Equity is shrinking by ~47.1% per year across the filed fiscal years. Its solvency ranks better than 7% of 1431 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability0=
Solvency0=
Growth72▲+17
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.32 against 0.41 in 2024; short-term debt: 309.9% and cash: 3.2% of total assets), and equity is negative.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 62
Relative position
BE, all sectors
reference
Computer programming, consultancy and related activities (NACE 62)
about 64% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 7 years 0 10 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-209.9%
Return on assets
-45.7%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
202122232425
2020 to 2025 · latest year -€698,793
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filings
Deviation from the deadline
2025
24 d late
2024
28 d late
2023
21 d late
2022
22 d late
2021
24 d late
2020
17 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 23 days after the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 33% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 7 February 2019, edenceHealth was incorporated.1 Revenue went from EUR 515,759 in 2020 to EUR 1.7 million in 2025 and headcount from 1.5 to 7.4 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2020 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€1.7m▼ 20.7%
2024 · €2.1m
EBIT margin
-6.5%▲ 8.7pp
2024 · -15.2%
Net result
-€152,200▲ 56.7%
2024 · -€351,751
Working capital
-€703,132▼ 25.8%
2024 · -€559,117
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€526,452▲ 2.1%€1.0m▲ 97.2%€3.4m▲ 228%€2.1m▼ 38.6%€1.7m▼ 20.7%
Operating result-€135,006▲ 22.1%€81,749€37,939▼ 53.6%-€318,664-€108,736▲ 65.9%
Net result-€145,511▲ 18.5%€60,070€7,159▼ 88.1%-€351,751-€152,200▲ 56.7%
EBIT margin-25.6%▲ 7.9pp7.9%▲ 33.5pp1.1%▼ 6.8pp-15.2%▼ 16.3pp-6.5%▲ 8.7pp
Equity-€262,072▼ 125%-€202,002▲ 22.9%-€194,843▲ 3.5%-€546,594▼ 181%-€698,793▼ 27.8%
Total assets€330,737▲ 4.9%€665,038▲ 101%€494,174▼ 25.7%€400,362▼ 19.0%€332,847▼ 16.9%
Debt€592,810▲ 37.3%€867,040▲ 46.3%€689,017▼ 20.5%€946,955▲ 37.4%€1.0m▲ 8.9%
Working capital-€245,735▼ 142%-€206,104▲ 16.1%-€215,451▼ 4.5%-€559,117▼ 160%-€703,132▼ 25.8%
Staff (FTE)3.8▲ 153%8▲ 111%7.8▼ 2.5%8.8▲ 12.8%7.4▼ 15.9%
Result per fiscal year
Operating resultNet result
-€400,000-€200,000€0Operating result 2021: -€135,006-€135,006Net result 2021: -€145,511-€145,511Operating result 2022: €81,749€81,749Net result 2022: €60,070€60,070Operating result 2023: €37,939€37,939Net result 2023: €7,159€7,159Operating result 2024: -€318,664-€318,664Net result 2024: -€351,751-€351,751Operating result 2025: -€108,736-€108,736Net result 2025: -€152,200-€152,20020212022202320242025-€400,000-€300,000-€200,000-€100,000€0Operating result 2023: €37,939€37,900Net result 2023: €7,159€7,160Operating result 2024: -€318,664-€319,000Net result 2024: -€351,751-€352,000Operating result 2025: -€108,736-€109,000Net result 2025: -€152,200-€152,000202320242025
The operating result stays negative: a loss of €108,736 in 2025 against €318,664 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €332,847
Fixed assets €4,431 ▼ 64.6%
Current assets €328,416 ▼ 15.3%
Key figures and ratios
2025 value · change against 2024
EBITDA
-€101,639▲
2024 · -€309,235
Cash flow
-€145,102▲
2024 · -€342,321
Solvency
-209.9%▼
2024 · -136.5%
Current ratio
0.32▼
2024 · 0.41
Quick ratio
0.26▼
2024 · 0.34
Debt to equity
-1.48▲
2024 · -1.73
ROA
-45.7%▲
2024 · -87.9%
Interest coverage
-2.39▲
2024 · -9.61
Debt ≤ 1 year
€1.0m▲
2024 · €946,955
Income taxes
€1,001▼
2024 · €1,380
Staff costs
€518,186▼
2024 · €610,428
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet Code20242025
Assets
Total assets20/58€400,362€332,847▼
Fixed assets21/28€12,523€4,431▼
Tangible fixed assets22/27€12,523€4,431▼
Plant, machinery and equipment23€12,523€4,431▼
Current assets29/58€387,838€328,416▼
Stocks and contracts in progress3€63,120€62,399▼
Contracts in progress37€63,120€62,399▼
Amounts receivable within one year40/41€292,330€248,838▼
Trade receivables40€276,151€235,467▼
Other amounts receivable41€16,179€13,372▼
Cash at bank and in hand54/58€21,720€10,561▼
Deferred charges and accrued income490/1€10,669€6,618▼
Equity and liabilities
Total equity and liabilities10/49€400,362€332,847▼
Equity10/15-€546,594-€698,793▼
Contributions10/11€62,000€62,000=
Capital10€62,000€62,000=
Issued capital100€62,000€62,000=
Profit (loss) carried forward14-€608,594-€760,793▼
Provisions and deferred taxes16-€92
Provisions for liabilities and charges160/5-€92
Pensions and similar obligations160-€92
Amounts payable17/49€946,955€1.0m▲
Amounts payable within one year42/48€946,955€1.0m▲
Trade debts44€271,859€226,242▼
Suppliers440/4€271,859€226,242▼
Advances received on contracts in progress46€51,556€249▼
Taxes, remuneration and social security45€71,594€56,674▼
Taxes450/3€4,036€1,897▼
Remuneration and social security454/9€67,558€54,777▼
Other amounts payable47/48€551,947€748,383▲
Income statement Code20242025
Turnover70€2.1m€1.7m▼
Goods, raw materials, services and sundry goods60/61€1.8m€1.5m▼
Remuneration, social security and pensions62€610,428€518,186▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9,429€7,098▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€28,788€21,477▲
Other operating charges640/8€3,079€10,859▲
Non-recurring operating charges66A-€68
Gross operating margin9900€275,484€448,951▲
Operating profit (loss)9901-€318,664-€108,736▲
Financial income75/76B€470€4▼
Recurring financial income75€470€4▼
Financial charges65/66B€32,176€42,466▲
Recurring financial charges65€32,176€42,466▲
Profit (loss) for the period before taxes9903-€350,371-€151,199▲
Income taxes67/77€1,380€1,001▼
Profit (loss) for the period9904-€351,751-€152,200▲
Profit (loss) for the period to be appropriated9905-€351,751-€152,200▲
Appropriation of the result
Profit (loss) to be appropriated9906-€608,594-€760,793▼
Profit (loss) brought forward from the previous period14P-€256,843-€608,594▼
Social balance
Average headcount (FTE)90878.87.4▼

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Turnover70€526,452€1.0m€3.4m€2.1m€1.7m▼ 20.7%
Goods, raw materials, services and sundry goods60/61€617,687€1.4m€1.9m€1.8m€1.5m▼ 14.9%
Remuneration, social security and pensions62€259,001€525,533€552,604€610,428€518,186▼ 15.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,418€6,266€8,982€9,429€7,098▼ 24.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€37,437-€28,788€21,477▲ 175%
Other operating charges640/8€2,092€2,075€2,169€3,079€10,859▲ 253%
Non-recurring operating charges66A----€68-
Gross operating margin9900€129,504€615,623€639,131€275,484€448,951▲ 63.0%
Operating profit (loss)9901-€135,006€81,749€37,939-€318,664-€108,736▲ 65.9%
Financial income75/76B-€3,276€17€470€4▼ 99.2%
Recurring financial income75-€3,276€17€470€4▼ 99.2%
Financial charges65/66B€9,498€24,979€28,297€32,176€42,466▲ 32.0%
Recurring financial charges65€9,498€24,979€28,297€32,176€42,466▲ 32.0%
Profit (loss) for the period before taxes9903-€144,504€60,046€9,660-€350,371-€151,199▲ 56.8%
Income taxes67/77€1,007-€24€2,501€1,380€1,001▼ 27.5%
Profit (loss) for the period9904-€145,511€60,070€7,159-€351,751-€152,200▲ 56.7%
Profit (loss) for the period to be appropriated9905-€145,511€60,070€7,159-€351,751-€152,200▲ 56.7%
Line20212022202320242025Change
Assets
Total assets20/58€330,737€665,038€494,174€400,362€332,847▼ 16.9%
Fixed assets21/28€11,525€11,964€20,608€12,523€4,431▼ 64.6%
Tangible fixed assets22/27€11,525€11,964€20,608€12,523€4,431▼ 64.6%
Plant, machinery and equipment23€11,525€11,964€20,608€12,523€4,431▼ 64.6%
Current assets29/58€319,212€653,073€473,565€387,838€328,416▼ 15.3%
Stocks and contracts in progress3€13,656€16,037€59,722€63,120€62,399▼ 1.1%
Contracts in progress37€13,656€16,037€59,722€63,120€62,399▼ 1.1%
Amounts receivable within one year40/41€283,547€620,043€386,580€292,330€248,838▼ 14.9%
Trade receivables40€199,819€450,642€346,621€276,151€235,467▼ 14.7%
Other amounts receivable41€83,728€169,401€39,958€16,179€13,372▼ 17.4%
Cash at bank and in hand54/58€12,998€9,637€20,308€21,720€10,561▼ 51.4%
Deferred charges and accrued income490/1€9,011€7,356€6,956€10,669€6,618▼ 38.0%
Equity and liabilities
Total equity and liabilities10/49€330,737€665,038€494,174€400,362€332,847▼ 16.9%
Equity10/15-€262,072-€202,002-€194,843-€546,594-€698,793▼ 27.8%
Contributions10/11€62,000€62,000€62,000€62,000€62,000=
Capital10€62,000€62,000€62,000€62,000€62,000=
Issued capital100€62,000€62,000€62,000€62,000€62,000=
Profit (loss) carried forward14-€324,072-€264,002-€256,843-€608,594-€760,793▼ 25.0%
Provisions and deferred taxes16----€92-
Provisions for liabilities and charges160/5----€92-
Pensions and similar obligations160----€92-
Amounts payable17/49€592,810€867,040€689,017€946,955€1.0m▲ 8.9%
Amounts payable within one year42/48€564,947€859,177€689,017€946,955€1.0m▲ 8.9%
Trade debts44€141,250€354,422€274,792€271,859€226,242▼ 16.8%
Suppliers440/4€141,250€354,422€274,792€271,859€226,242▼ 16.8%
Advances received on contracts in progress46€85,091€35,716€31,339€51,556€249▼ 99.5%
Taxes, remuneration and social security45€16,184€60,176€57,076€71,594€56,674▼ 20.8%
Taxes450/3€2,665€734€2,501€4,036€1,897▼ 53.0%
Remuneration and social security454/9€13,519€59,443€54,576€67,558€54,777▼ 18.9%
Other amounts payable47/48€322,423€408,863€325,809€551,947€748,383▲ 35.6%
Accrued charges and deferred income492/3€27,863€7,863----
Line20212022202320242025Change
Profit (loss) for the period9904-€145,511€60,070€7,159-€351,751-€152,200▲ 56.7%
+ Depreciation and write-downs630€3,418€6,266€8,982€9,429€7,098▼ 24.7%
Operating cash flow (approximation)-€142,093€66,336€16,141-€342,321-€145,102▲ 57.6%
Investment in fixed assets (approximation)--€6,705-€17,625-€1,344€995▲ 174%
Change in cash--€3,361€10,671€1,411-€11,159▼ 891%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
24-08
NBB filing Annual accounts filed
fiscal year 2025 · full schema · 24 days late
2025
28-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 28 days late
2024
31-12
Financial Weakest financial yearnet -€351,751
Net result drops to -€351,751, the lowest in the series; recovery starts the following year.
21-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 21 days late
2023
22-08
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 22 days late
2022
31-12
Financial Back to profitnet €60,070
Net result €60,070 after 2 loss-making years.
24-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 24 days late
2021
17-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 17 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 8 acts read
About the unread acts

We know of 8 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
8 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kontich · 1 establishment unit since 2019
seat establishment approximate The establishment unit on the map
Ground area
3,333 m²
Building footprint
933 m²
Volume, LiDAR
7,846 m³
Parcel 11024B0079/00F000, Flanders · tallest building 10.3 m, ±3 floors. Linked by address, not a title deed.
79 companies at this address See who is registered here
1 establishment unit
edenceHealth
Veldkant 33 A, 2550 KontichOther business support services
since 20192.288.838.625
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11024B0079/00F000 Flanders 3,333 m² 1 · 932 m² 10.3 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Part of the group Nuclys 46 companies Group, risk and exposure

Connections & network

No current directors or connected companies found in the register.

Ownership & control

2 parent companies
Control over this companyparent company per the LEI register2
Kontich · indirect · LEI lapsed
controls
edenceHealthBE 0719.961.021

Public money · subsidies and aid

Flemish government

2022 to 2025 · 5 entries · 29,099 EUR awarded · 29,099 EUR paid
Year Entries awardedpaid
2025 1 3,001 EUR3,001 EUR
2024 1 8,006 EUR8,006 EUR
2023 1 10,502 EUR10,502 EUR
2022 2 7,590 EUR7,590 EUR
Schemes
4 entries · 26,833 EUR · 26,833 EUR paid · Departement Werk en Sociale Economie
1 entry · 2,266 EUR · 2,266 EUR paid · Departement Werk en Sociale Economie

European Union, budget

2023 · 1 entry · 137,808 EUR in total
Year Entries awarded
2023 1 137,808 EUR
Projects
DIGIONE I3 - DIGITAL INFRASTRUCTURE FOR ONCOLOGY IN EUROPE
European Regional Development Fund · 01-11-2023 to 30-04-2026 · 137,808 EUR

European research

1 project · 278,250 EUR EU contribution
Programmes
1 entry · 278,250 EUR
Projects
Scaling Up Research in SSA Countries in Infectious Diseases: African-European Training Network in Integrated Health Informatics and Data Sciences
Horizon Europe · participant · 01-10-2024 to 31-03-2029 · 278,250 EUR · BRIDGE NETWORK

Recognitions · licences · registrations

Legal Entity Identifier

6994000DIXRQVLM1IG69
live in the LEI register

Similar companies · same sector, comparable size

Of 30,002 companies in sector 62200 we hold annual accounts for 18,394. 1,763 are within a factor 10 of this headcount. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded07-02-2019
Fiscal year end31-12
Activities, NACEBEL 2025
62200Computer consultancy and computer facilities management

Scores and ratios are computed by Checked and are not a credit decision.